Literature DB >> 31202257

Characteristics and prognostic factors of age-stratified high-grade intracranial glioma patients: A population-based analysis.

Yun Sun1, Zhi-Yong Xiong, Peng-Fei Yan, Liang-Lei Jiang, Chuan-Sheng Nie, Xuan Wang.   

Abstract

We evaluated characteristics and different prognostic factors for survival in age-stratified high-grade glioma in a U.S. cohort. Eligible patients were identified in the Surveillance, Epidemiology, and End Results (SEER) registries and stratified into 3 age groups: 20-39 years old (1,043 patients), 40-59 years old (4,503 patients), and >60 years old (5,045 patients). Overall and cancer-related survival data were obtained. Cox models were built to analyze the outcomes and risk factors. It showed that race was a prognostic factor for survival in patients 40 to 59 years old and in patients ≥60 years old. Partial resection was associated with lower overall survival and cause-specific survival in all age groups (overall survival: 20-39 yr: HR = 6.41; 40-59 yr: HR = 4.84; >60 yr: HR = 5.06; cause-specific survival: 20-39 yr: HR = 5.87; 40-59 yr: HR = 4.01; >60 yr: HR = 3.36). The study highlights that, while some prognostic factors are universal, others are age-dependent. The effectiveness of treatment approaches differs for patients in different age groups. Results of this study may help to develop personalized treatment protocols for glioma patients of different ages.

Entities:  

Mesh:

Year:  2019        PMID: 31202257      PMCID: PMC6868482          DOI: 10.17305/bjbms.2019.4213

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  27 in total

1.  Racial/ethnic differences in survival among elderly patients with a primary glioblastoma.

Authors:  Jill S Barnholtz-Sloan; John L Maldonado; Vonetta L Williams; William T Curry; Elizabeth A Rodkey; Frederick G Barker; Andrew E Sloan
Journal:  J Neurooncol       Date:  2007-05-26       Impact factor: 4.130

Review 2.  The Updated World Health Organization Glioma Classification: Cellular and Molecular Origins of Adult Infiltrating Gliomas.

Authors:  David J Pisapia
Journal:  Arch Pathol Lab Med       Date:  2017-12       Impact factor: 5.534

3.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.

Authors:  Quinn T Ostrom; Haley Gittleman; Jordan Xu; Courtney Kromer; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2016-10-01       Impact factor: 12.300

4.  The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.

Authors:  Chad G Rusthoven; Julie A Carlson; Timothy V Waxweiler; Miranda J Dally; Anna E Barón; Norman Yeh; Laurie E Gaspar; Arthur K Liu; Douglas E Ney; Denise M Damek; Kevin O Lillehei; Brian D Kavanagh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-18       Impact factor: 7.038

5.  Survival of Ventricular and Periventricular High-Grade Gliomas: A Surveillance, Epidemiology, and End Results Program-Based Study.

Authors:  Wuyang Yang; Tao Xu; Tomas Garzon-Muvdi; Changchuan Jiang; Judy Huang; Kaisorn L Chaichana
Journal:  World Neurosurg       Date:  2017-12-16       Impact factor: 2.104

6.  Prognostic factors and survival in primary adult high grade brainstem astrocytoma: a population based study from 1973-2008.

Authors:  Mahua Dey; Yimo Lin; Stephanie Melkonian; Sandi Lam
Journal:  J Clin Neurosci       Date:  2014-01-24       Impact factor: 1.961

Review 7.  Hereditary tumor syndromes and gliomas.

Authors:  David Reuss; Andreas von Deimling
Journal:  Recent Results Cancer Res       Date:  2009

8.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

Review 9.  Glioblastoma multiforme: a review of where we have been and where we are going.

Authors:  Cory Adamson; Okezie O Kanu; Ankit I Mehta; Chunhui Di; Ningjing Lin; Austin K Mattox; Darell D Bigner
Journal:  Expert Opin Investig Drugs       Date:  2009-08       Impact factor: 6.206

10.  Prognostic factors for long-term survival after glioblastoma.

Authors:  Mohammad Sami Walid
Journal:  Perm J       Date:  2008
View more
  3 in total

1.  The current state of glioma data registries.

Authors:  Alexander G Yearley; Julian Bryan Iorgulescu; Ennio Antonio Chiocca; Pier Paolo Peruzzi; Timothy R Smith; David A Reardon; Michael A Mooney
Journal:  Neurooncol Adv       Date:  2022-06-24

2.  GLIMPSE: a glioblastoma prognostication model using ensemble learning-a surveillance, epidemiology, and end results study.

Authors:  Kamel A Samara; Zaher Al Aghbari; Amani Abusafia
Journal:  Health Inf Sci Syst       Date:  2021-01-12

3.  ABCB1 Is Frequently Methylated in Higher-Grade Gliomas and May Serve as a Diagnostic Biomarker of More Aggressive Tumors.

Authors:  Aleksandra Majchrzak-Celińska; Arvinder Sidhu; Izabela Miechowicz; Witold Nowak; Anna-Maria Barciszewska
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.